banning tirzepatide Lilly's weight-loss drug removed from FDA's shortage list Is Compounded Tirzepatide Safe or

Benefits Phase 3 (TRIUMPH-4): 28.7% average body weight loss at 68 weeks (26.6% placebo-adjusted) approximately 71.2 lbs at the 12 mg dose (Eli Lilly topline results, December 2025

Tirzepatide robustly lowered glycemia during the IPGTT, an effect that was completely blocked by GLP-1R antagonism (Fig

Always consult with a qualified healthcare provider before starting, stopping, or modifying any medication or treatment plan

While cardio has long been the default recommendation for weight loss, strength training offers something cardio cannot: the preservation and development of lean muscle mass during a period of significant calorie deficit

Dizziness occurs in some patients, often related to dehydration or rapid blood pressure changes associated with weight loss